Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

2019186 citationsJournal Articlehybrid Open Access

Authors

Patients achieved clinical benefit from maintenance treatment with niraparib regardless of response to the last platinum-based therapy.

Good health and well-being

Published in: Journal of Clinical Oncology

Volume 37, Issue 32, pp. 2968-2973

Field-Weighted Citation Impact: 8.39